|
AU2008201480A1
|
|
Crystals of Whole Antibodies and Fragments Thereof and Methods for Making and Using Them
|
|
AU2007333959A1
|
|
Human growth hormone formulations
|
|
AU2007347695A1
|
|
Crystallized oxalate decarboxylase and methods of use
|
|
CN101583375A
|
|
Crystallized oxalate decarboxylase and methods of use
|
|
WO2007076131A2
|
|
Compositions comprising polycation-complexed protein crystals and methods of treatment using them
|
|
CA2610159A1
|
|
Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
|
|
MX2007004534A
|
|
Compositions containing lipase; protease and amylase for treating pancreatic insufficiency.
|
|
KR20060127857A
|
|
Non-pancreatic proteases for controlling plasma cholecystokinin(cck) concentration and for treating pain
|
|
EP1585771A1
|
|
Complexes of protein crystals and ionic polymers
|
|
CN101659701A
|
|
Human growth hormone crystals and methods for preparing them
|
|
EP1801123A2
|
|
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
|
EP2311436A1
|
|
Stabilized protein crystals, formulations containing them and methods of making them
|
|
EP1009759A1
|
|
Carbohydrate crosslinked glycoprotein crystals
|
